ClariVest Asset Management’s Catalyst Pharmaceutical CPRX Stock Holding History
| Quarter | Market Value | Status | Shares |
Shares Change % | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2024
Q2 | – | Sell |
-73,967
| Closed | -$1.18M | – | 866 |
|
|
2024
Q1 | $1.18M | Buy |
73,967
+138
| +0.2% | +$2.2K | 0.12% | 236 |
|
|
2023
Q4 | $1.24M | Sell |
73,829
-13,268
| -15% | -$223K | 0.07% | 212 |
|
|
2023
Q3 | $1.02M | Hold |
87,097
| – | – | 0.06% | 234 |
|
|
2023
Q2 | $1.17M | Buy |
87,097
+15,770
| +22% | +$212K | 0.06% | 215 |
|
|
2023
Q1 | $1.18M | Sell |
71,327
-73
| -0.1% | -$1.21K | 0.05% | 260 |
|
|
2022
Q4 | $1.33M | Sell |
71,400
-1,000
| -1% | -$18.6K | 0.06% | 236 |
|
|
2022
Q3 | $929K | Hold |
72,400
| – | – | 0.04% | 268 |
|
|
2022
Q2 | $507K | Hold |
72,400
| – | – | 0.02% | 374 |
|
|
2022
Q1 | $601K | Buy |
+72,400
| New | +$601K | 0.02% | 357 |
|
|
2021
Q2 | – | Sell |
-137,400
| Closed | -$634K | – | 764 |
|
|
2021
Q1 | $634K | Buy |
137,400
+7,600
| +6% | +$35.1K | 0.02% | 376 |
|
|
2020
Q4 | $434K | Sell |
129,800
-1,800
| -1% | -$6.02K | 0.01% | 405 |
|
|
2020
Q3 | $391K | Sell |
131,600
-8,000
| -6% | -$23.8K | 0.01% | 382 |
|
|
2020
Q2 | $645K | Sell |
139,600
-8,100
| -5% | -$37.4K | 0.02% | 366 |
|
|
2020
Q1 | $569K | Sell |
147,700
-9,300
| -6% | -$35.8K | 0.02% | 388 |
|
|
2019
Q4 | $588K | Sell |
157,000
-1,700
| -1% | -$6.37K | 0.01% | 412 |
|
|
2019
Q3 | $843K | Hold |
158,700
| – | – | 0.02% | 363 |
|
|
2019
Q2 | $610K | Buy |
+158,700
| New | +$610K | 0.01% | 350 |
|